glp-1 pfizer Ole Miss researchers study barriers to insurance coverage Pfizer to discontinue danuglipron, its

The FDA specifically noted that "multiple reports of adverse events, some requiring hospitalization" were related to dosing errors with compounded and grey market injectable tirzepatide products

Nervous system health

In acid sphingomyelinase knock-out mice, which mimic a neurovisceral acid sphingomyelinase deficiency (ASMD) characterized by cellular accumulation of sphingomyelin, the effects of a choline-free diet decreased the activation of liver macrophages and microglia, but it did not significantly alter sphingomyelin levels due to compensatory mechanisms involving methionine metabolism (101)

Molnar T, Lehoczki A, Fekete M, et al

Conversely, those with GLP1R variants showing reduced receptor sensitivity might benefit most from higher GLP-1 dosing paired with naltrexone for synergistic effect